![]() |
Neogenix Oncology To Present Data On Its Novel Antibody, NEO-201 At AACR's 2011 Annua
Neogenix Oncology, Inc. announced that members of its scientific staff will present laboratory studies of NEO-201, a novel monoclonal antibody in development to diagnose and treat solid tumors of the gastrointestinal tract, lung and respiratory tract, breast, and ovarian cancers...
More... |
| All times are GMT -7. The time now is 04:48 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021